Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 11/2011

01.11.2011 | Original Article

Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin

verfasst von: Hui Li, Hua Zhao, Jinpu Yu, Yanjun Su, Shui Cao, Xiumei An, Xiubao Ren

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Expansion of CD4+CD25+ regulatory T cells (Tregs) in tumor microenvironment was one of the mechanisms by which cancer cells escaped host defense. Thymic stromal lymphopoietin (TSLP) contributes to the generation of natural Tregs in thymus. Therefore, the purpose of this report was to investigate the role of TSLP in the increasing prevalence of Tregs in lung cancer microenvironment. The expression ratio of TSLP protein in tumor tissues was significantly increased compared with that in benign lesion and non-cancer lung tissue. The prevalence of Tregs in tumor microenvironment was correlated with the expression of TSLP in lung cancer. Dendritic cells (DCs) were induced from peripheral blood mononuclear cells (PBMCs) collected from lung cancer patients and left unstimulated (imDCs) or exposed to hTSLP (TSLP-DCs) or LPS (LPS-DCs). TSLP-DCs expressed intermediate levels of CD83 and high levels of CD86, CD11C, and HLA-DR, which showed a characteristic of less mature DCs. TSLP-DCs secreted low levels of IL-6, IL-12, IL-10, TNF-α and IFN-γ, and high levels of TGF-β and MDC. The percentage of Tregs in CD4+CD25− T cells cocultured with TSLP-DCs group was statistically higher than that of LPS-DCs and imDCs. Transwell assays showed that TSLP-DCs exhibited increased ability to attract the migration of CD4+CD25− Tregs, when compared with imDCs. These results indicated that TSLP proteins were expressed in lung tumor tissue and correlated with the prevalence of Tregs. TSLP-DCs could induce CD4+CD25− T cells to differentiate into CD4+CD25+foxp3+ T cells and the migration of CD4+CD25+ T cells.
Literatur
1.
Zurück zum Zitat Ohara M, Yamaguchi Y, Matsuura KM et al (2009) Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer. Cancer Immunol Immunother 58(3):441–447 Ohara M, Yamaguchi Y, Matsuura KM et al (2009) Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer. Cancer Immunol Immunother 58(3):441–447
2.
Zurück zum Zitat Li L, Chao QG, Ping LZ et al (2009) The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. Cancer Biother Radiopharm 24(3):357–367PubMedCrossRef Li L, Chao QG, Ping LZ et al (2009) The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. Cancer Biother Radiopharm 24(3):357–367PubMedCrossRef
3.
Zurück zum Zitat Tokuno K, Hazama S, Yoshino S et al (2009) Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer. Anticancer Res 29(5):1527–1532PubMed Tokuno K, Hazama S, Yoshino S et al (2009) Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer. Anticancer Res 29(5):1527–1532PubMed
4.
Zurück zum Zitat Strauss L, Bergmann C, Szczepanski M et al (2007) A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment. Clin Cancer Res 13(15):4345–4354 Strauss L, Bergmann C, Szczepanski M et al (2007) A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment. Clin Cancer Res 13(15):4345–4354
5.
Zurück zum Zitat Daniel J, Campbell DJ, Koch MA (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11:119–130CrossRef Daniel J, Campbell DJ, Koch MA (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11:119–130CrossRef
6.
Zurück zum Zitat Liu VC, Wong LY, Jang T et al (2007) Tumor evasion of the immune system by converting CD4+CD25− T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178(5):2883–2892PubMed Liu VC, Wong LY, Jang T et al (2007) Tumor evasion of the immune system by converting CD4+CD25− T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178(5):2883–2892PubMed
7.
Zurück zum Zitat Banerjee DK, Dhodapkar MV, Matayeva E et al (2006) Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108(8):2655–2661PubMedCrossRef Banerjee DK, Dhodapkar MV, Matayeva E et al (2006) Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108(8):2655–2661PubMedCrossRef
8.
Zurück zum Zitat Watanabe N, Wang YH, Lee HK et al (2005) Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436:1181–1185PubMedCrossRef Watanabe N, Wang YH, Lee HK et al (2005) Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436:1181–1185PubMedCrossRef
9.
Zurück zum Zitat Lee JY, Lim YM, Park MJ et al (2008) Murine thymic stromal lymphopoietin promotes the differentiation of regulatory T cells from thymic CD4(+)CD8(−)CD25(−) naive cells in a dendritic cell-independent manner. Immunol Cell Biol 86:206–213 Lee JY, Lim YM, Park MJ et al (2008) Murine thymic stromal lymphopoietin promotes the differentiation of regulatory T cells from thymic CD4(+)CD8(−)CD25(−) naive cells in a dendritic cell-independent manner. Immunol Cell Biol 86:206–213
10.
Zurück zum Zitat Ito T, Wang YH, Duramad O et al (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202(9):1213–1223 Ito T, Wang YH, Duramad O et al (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202(9):1213–1223
11.
Zurück zum Zitat Vosshenrich CA, Cumano A, Müller W et al (2004) Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment. Proc Natl Acad Sci USA 101:11070–11075PubMedCrossRef Vosshenrich CA, Cumano A, Müller W et al (2004) Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment. Proc Natl Acad Sci USA 101:11070–11075PubMedCrossRef
12.
Zurück zum Zitat Ramalingam TR, Pesce JT, Mentink-Kane MM et al (2009) Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin. J Immunol 182(10):6452–6459PubMedCrossRef Ramalingam TR, Pesce JT, Mentink-Kane MM et al (2009) Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin. J Immunol 182(10):6452–6459PubMedCrossRef
13.
Zurück zum Zitat Li YL, Li HJ, Ji F et al (2010) Thymic stromal lymphopoietin promotes lung inflammation through activation of dendritic cells. J Asthma 47(2):117–123PubMedCrossRef Li YL, Li HJ, Ji F et al (2010) Thymic stromal lymphopoietin promotes lung inflammation through activation of dendritic cells. J Asthma 47(2):117–123PubMedCrossRef
14.
Zurück zum Zitat Soumelis V, Reche PA, Kanzler H et al (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673–680PubMedCrossRef Soumelis V, Reche PA, Kanzler H et al (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673–680PubMedCrossRef
15.
Zurück zum Zitat Liu YJ, Soumelis V, Watanabe N et al (2007) TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25:193–219 Liu YJ, Soumelis V, Watanabe N et al (2007) TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25:193–219
16.
Zurück zum Zitat Fan H, Wang J, Zhou X et al (2009) Induction of antigen-specific immune tolerance by TGF-beta induced CD4+foxp3+ regulatory T cells. Int J Clin Exp Med 2(3):212–220PubMed Fan H, Wang J, Zhou X et al (2009) Induction of antigen-specific immune tolerance by TGF-beta induced CD4+foxp3+ regulatory T cells. Int J Clin Exp Med 2(3):212–220PubMed
17.
Zurück zum Zitat Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798–809PubMedCrossRef Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798–809PubMedCrossRef
18.
Zurück zum Zitat Adach A, Ellert-Miklaszewska A, Kaminska B (2009) Molecular characterization of STAT signaling in inflammation and tumorigenesis. Methods Mol Biol 512:265–278PubMedCrossRef Adach A, Ellert-Miklaszewska A, Kaminska B (2009) Molecular characterization of STAT signaling in inflammation and tumorigenesis. Methods Mol Biol 512:265–278PubMedCrossRef
19.
Zurück zum Zitat Bensinger SJ, Walsh PT, Zhang J et al (2004) Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol 172(9):5287–5296PubMed Bensinger SJ, Walsh PT, Zhang J et al (2004) Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol 172(9):5287–5296PubMed
20.
Zurück zum Zitat Hanabuchi S, Ito T, Park WR et al (2010) Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol 184(6):2999–3007PubMedCrossRef Hanabuchi S, Ito T, Park WR et al (2010) Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol 184(6):2999–3007PubMedCrossRef
21.
Zurück zum Zitat Gobert M, Treilleux I, Bendriss-Vermare N et al (2009) Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 69(5):2000–2009PubMedCrossRef Gobert M, Treilleux I, Bendriss-Vermare N et al (2009) Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 69(5):2000–2009PubMedCrossRef
22.
Zurück zum Zitat Qin XJ, Shi HZ, Deng JM et al (2009) CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res 15(7):2231–2237PubMedCrossRef Qin XJ, Shi HZ, Deng JM et al (2009) CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res 15(7):2231–2237PubMedCrossRef
Metadaten
Titel
Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin
verfasst von
Hui Li
Hua Zhao
Jinpu Yu
Yanjun Su
Shui Cao
Xiumei An
Xiubao Ren
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 11/2011
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-011-1059-6

Weitere Artikel der Ausgabe 11/2011

Cancer Immunology, Immunotherapy 11/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.